SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Tatva Chintan Pharma - Quaterly Results

18 Jul 2026 Evaluate
A decent increase of about 34.37% in the sales to Rs. 1467.02 millions was observed for the quarter ended June 2026. The sales figure stood at Rs. 1091.80 millions during the year-ago period.The Total revenue for the quarter ended June 2026 of  Rs. 104.46  millions  grew by 103.51% from Rs. 51.33 millions.Operating profit surged to 280.58 millions from the corresponding previous quarter of 164.36 millions.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202606 202506 % Var 202606 202506 % Var 202603 202503 % Var
Sales 1467.02 1091.80 34.37 1467.02 1091.80 34.37 4962.96 3664.15 35.45
Other Income 40.33 13.69 194.59 40.33 13.69 194.59 35.28 35.61 -0.93
PBIDT 280.58 164.36 70.71 280.58 164.36 70.71 928.58 294.05 215.79
Interest 20.81 4.13 403.87 20.81 4.13 403.87 28.51 12.90 121.01
PBDT 246.59 160.23 53.90 246.59 160.23 53.90 900.07 281.15 220.14
Depreciation 105.65 89.69 17.79 105.65 89.69 17.79 368.42 276.54 33.22
PBT 140.94 70.54 99.80 140.94 70.54 99.80 531.65 4.61 11432.54
TAX 36.48 19.21 89.90 36.48 19.21 89.90 140.83 1.34 10409.70
Deferred Tax 36.48 7.09 414.53 36.48 7.09 414.53 40.16 1.32 2942.42
PAT 104.46 51.33 103.51 104.46 51.33 103.51 390.82 3.27 11851.68
Equity 233.92 233.92 0.00 233.92 233.92 0.00 233.92 233.92 0.00
PBIDTM(%) 19.13 15.05 27.05 19.13 15.05 27.05 18.71 8.03 133.15

Tatva Chintan Pharma Share Price

1750.45 27.60 (1.60%)
29-Jul-2026 16:01 View Price Chart
Peers
Company Name CMP
SRF 2640.10
BASF India 3735.80
Pidilite Inds. 1630.00
Tata Chemicals 678.40
GNFC 525.30
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through: